X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
Enter email and you're done. No subscription, no credit card.
Search, tap and you're done. Over 3,400 medicines.
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Ondansetron belongs to the setrons and blocks the serotonin receptors through which chemotherapy, radiotherapy and operations trigger nausea and vomiting. It works mainly in the first 24 hours after chemotherapy and is usually well tolerated — with one typical downside: constipation, which in cancer treatment coincides with many other causes. Rarer, but important, is a possible change in heart rhythm (QT prolongation).
See more detail.gif)
Nausea in cancer treatment is not a single problem but several, with different mechanisms. Once you know that, you can see why "more ondansetron" is often the wrong answer.²,³
| Form | Timing | What ondansetron achieves | What tends to help more |
|---|---|---|---|
| Acute nausea | First 24 hours after chemotherapy | Works well — this is where its strength lies | A combination depending on the emetogenic risk |
| Delayed nausea | Days 2 to 5 | Little additional benefit | Dexamethasone, NK1 receptor antagonists, sometimes olanzapine |
| Anticipatory nausea | Before treatment, triggered by smells, places, thoughts | No effect | Good control from the start, relaxation techniques, behavioural therapy, sometimes short-term lorazepam |
| Breakthrough nausea | Despite prevention | Limited if already given | A medicine from another group, such as metoclopramide or olanzapine, as directed by the team |
Anticipatory nausea deserves particular attention. It develops when earlier cycles were associated with severe nausea: the body learns the connection, and even the smell of the clinic or the journey there triggers nausea. The best prevention is therefore to control nausea consistently from the very first cycle.
Not all nausea during cancer treatment comes from the chemotherapy. Constipation, opioid painkillers, an irritated stomach lining, an inflamed lining of the mouth, infections, altered blood salts, anxiety or, more rarely, changes in the brain can also cause nausea. If it lasts unusually long or does not fit the previous pattern, it should be investigated rather than simply increasing the dose.
Ondansetron can prolong the so-called QT interval on the ECG in a dose-dependent way — the phase in which the heart's ventricles recover electrically after each beat. A markedly prolonged QT interval increases the risk of dangerous heart rhythm disorders. That is why the maximum single intravenous dose has been capped, and according to the SmPC ondansetron should be avoided in congenital long QT syndrome.¹
For most people the risk is low. It rises, however, when several factors come together — and in cancer treatment that is not unusual:
In these situations, ECG checks and checks of blood salts can make sense. If you notice heart palpitations, a racing heart or dizzy spells during treatment, tell the team.
The most important interactions concern the heart rhythm, the serotonin system and constipation.¹
| Combination | Consequence | What to do |
|---|---|---|
| Apomorphine (a Parkinson's medicine) | Severe drops in blood pressure, even loss of consciousness, have been described | Contraindicated — do not combine |
| QT-prolonging medicines, such as citalopram, escitalopram, azithromycin, quetiapine, haloperidol, methadone | Additive QT prolongation, risk of rhythm disorders | Weigh up medically; check the ECG and blood salts if needed |
| Chemotherapy drugs that strain the heart, e.g. anthracyclines | Increased risk of rhythm disorders | Monitoring as directed by the team |
| Serotonergic medicines such as sertraline, venlafaxine, duloxetine | Rarely serotonin syndrome | Watch out for restlessness, trembling, fever, muscle twitching |
| Tramadol | Pain relief may be weakened; tramadol is also serotonergic | Raise it if your pain is not well controlled |
| Opioids, iron, other constipating medicines | Constipation gets worse | Discuss preventive laxatives from the start |
| Diuretics such as furosemide | Potassium loss and therefore a higher QT risk | Have your blood salts checked |
| Strong enzyme inducers such as rifampicin, phenytoin or carbamazepine | Lower ondansetron levels, weaker effect | Raise it if the effect is inadequate |
In cancer treatment, ten or more medicines quickly add up, prescribed by the oncology team, the GP practice and the hospital. A complete medication plan and an interaction check help ensure that QT and serotonin risks are not overlooked. Alcohol worsens nausea and puts additional strain on the stomach and liver — on treatment days, going without it is the best choice.
Some large observational studies pointed to a slightly increased risk of cleft lip and palate when ondansetron was taken in the first trimester of pregnancy. The European Medicines Agency therefore recommended in 2019 that ondansetron should not be used in the first trimester; women of childbearing age should be advised on contraception.⁵ Embryotox rates the possible risk as low and considers its use in severe pregnancy sickness justifiable when better-tested medicines are not enough — a decision made on an individual basis.⁶ The SmPC advises against breastfeeding while taking ondansetron. General information is in the guide medications during pregnancy.
Ondansetron is licensed for children to prevent nausea during chemotherapy and after operations, with age-dependent restrictions. The dose is based on body weight or body surface area and is set exclusively by a doctor.¹
In older age, ondansetron is broken down more slowly; lower starting doses apply to intravenous administration. With moderate to severe liver impairment, the SmPC sets an upper limit of 8 mg a day. With impaired kidney function, no adjustment is usually needed. Older people are also more prone to constipation and dehydration — both deserve particularly close attention in this age group.¹
It is working — just not where the problem now lies. Ondansetron is strong in the first 24 hours, but delayed nausea from the second day onwards is mediated mainly by other messenger substances. More ondansetron then achieves little and tends to make constipation worse. Talk to your team about the delayed phase: there are combinations with dexamethasone, NK1 receptor antagonists or other medicines for it. And check when you last had a bowel movement — constipation from day three onwards can explain the nausea on its own.
Contact your oncology team or the outpatient clinic today — not at your next appointment. Adjusting the laxative is often enough, but that should be decided by someone who knows your blood counts and your medicines. Go to the emergency department immediately if you are no longer passing wind either, your abdomen is very painful and bloated, or you are vomiting despite anti-sickness medicines. For the next cycles: prevention from the start, and keep count of your bowel movements.
That is anticipatory nausea — a learned reaction to earlier cycles, not something you are imagining. Ondansetron does not help against it, because the trigger lies in the mind, not in the gut. Relaxation techniques, distraction, behavioural therapy and sometimes a short-term sedative before treatment are effective. Raise it openly; psycho-oncology services know this problem well. At the same time, it is worth stepping up prevention for the next cycles so that the association does not become even more entrenched.
The interaction check shows QT and serotonin risks in your medication list.
